Publications des scientifiques de l'IRD

Cassidy-Seyoum S., Vongsouvath M., Sengvilaipaseuth O., Seephonelee M., Bharucha T., Lamballerie X. de, Newton P. N., Dubot Pérès Audrey. (2019). Rapid diagnostic tests as a source of dengue virus RNA for envelope gene amplification : a proof of concept. American Journal of Tropical Medicine and Hygiene, 101 (2), p. 451-455. ISSN 0002-9637.

Titre du document
Rapid diagnostic tests as a source of dengue virus RNA for envelope gene amplification : a proof of concept
Année de publication
2019
Type de document
Article référencé dans le Web of Science WOS:000486536800012
Auteurs
Cassidy-Seyoum S., Vongsouvath M., Sengvilaipaseuth O., Seephonelee M., Bharucha T., Lamballerie X. de, Newton P. N., Dubot Pérès Audrey
Source
American Journal of Tropical Medicine and Hygiene, 2019, 101 (2), p. 451-455 ISSN 0002-9637
Molecular epidemiological data are key for dengue outbreak characterization and preparedness. However, sparse Dengue virus (DENV) molecular information is available in Laos because of limited resources. In this proof-of-concept study, we evaluated whether DENV1 RNA extracted from rapid diagnostic tests (RDTs) could be amplified and sequenced. The protocol for envelope gene amplification from RNA purified from RDTs was first assessed using viral isolate dilutions then conducted using 14 dengue patient sera. Envelope gene amplification was successful from patient sera with high virus titer, as was sequencing but with lower efficiency. Hence, based on our results, RDTs can be a source of DENV1 RNA for subsequent envelope gene amplification and sequencing. This is a promising tool for collecting molecular epidemiology data from rural dengue-endemic areas. However, further investigations are needed to improve assay efficiency and to assess this tool's level of efficacy on a larger scale in the field.
Plan de classement
Sciences fondamentales / Techniques d'analyse et de recherche [020] ; Entomologie médicale / Parasitologie / Virologie [052]
Description Géographique
LAOS
Localisation
Fonds IRD [F B010077016]
Identifiant IRD
fdi:010077016
Contact